CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oppenheimer Adjusts Ovid Therapeutics Price Target to $9 From $7, Maintains Outperform Rating

Positive
AI Analysis

Summary

Oppenheimer raised its price target for Ovid Therapeutics from $7 to $9 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.30
analyst_ratingprice_targetOVID
Related Companies

Read the original article

Published by yahoo_finance on August 3, 2026 12:54 PM

Read Original